Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Julphar Insulin 30/70 vs Huminsulin Profil III in Healthy Subjects
NCT02631928Phase 1Completed
- Sponsor
- Julphar
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Insulin human regular + insulin isophane in diabetes mellitus (DM) (2 arms), sponsored by Julphar. Primary endpoints: Area under the serum insulin concentration curve from 0-24 hours and Maximum observed insulin concentration at 24 hours. Started Feb 2016; status: completed.
02
Drugs
Insulin human regular + insulin isophane
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02631928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631928.